Lenovo Unveils New Generation of AI PC Desktops and Monitors Designed to Maximize Productivity and Multitasking
Lenovo™ unveiled its new generation of business devices for modern workplaces, featuring a comprehensive selection of AI-powered ThinkCentre M Series Gen 6 desktops and the ThinkVision T Series Gen 40 monitors. Designed to address the needs of businesses of all sizes, the ThinkCentre family of desktops combine performance and reliability in different form factors, including tower, compact and all-in-one (AIO), while the ThinkVision T Series monitors blend outstanding display, connectivity, and manageability.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250514137029/en/
“Nearly half of businesses believe that AI-powered devices boost employee productivity, and 90 percent of those are already piloting, planning or exploring AI-powered PC rollouts, according to a recent Lenovo and IDC global survey of IT decision-makers. AI has and will continue to reshape the future of work, and Lenovo is proud to lead the way with a new generation of AI desktop PCs and monitors that meet the changing needs of businesses in this new era,” said Johnson Jia, senior vice president of Intelligent Devices Group’s Global Innovation Center at Lenovo. “Our latest ThinkCentre M Series Gen 6 desktops and ThinkVision T Series Gen 40 monitors power businesses of all sizes with scalable performance to unlock next-gen AI productivity and creativity.”
Scalable Power and Towering Performance
An uncompromised blend of power and expandability, Lenovo’s ThinkCentre M Series Gen 6 tower and small form factor desktops are engineered for the most demanding business environments. Designed for AI model training, 3D designs, data analysis and more, the desktops provide maximum TOPs performance from a combination of CPU and discrete NPU and GPU, and outstanding connectivity with a variety of ports. Tower models such as the ThinkCentre M90t Gen 6 are equipped with up to Intel vPro® Enterprise with AI-capable Intel® Core™ Ultra 9 Processors (Series 2), DDR5 memory support and 8 expansion slots that makes it futureproof.
Big Capability with a Tiny Footprint
Ideal for compact settings, the ThinkCentre M Series Gen 6 desktops also come in a compact, 1L design that can fit or hide behind a monitor screen or even inside a desk drawer. Ideal for healthcare, retail, and financial industries, these tiny desktops deliver full-size enterprise-level AI performance and can be fully customized, from components to accessories such as mounting options. Select models, including the ThinkCentre M90q Gen 6 can be powered by up to an Intel® Core™ Ultra 9 processor, supports up to four displays and can come with an option discrete NPU at 30 TOPs for protected on-device AI.
Streamlined Design Meets AI Intelligence
For companies demanding clutter-free AI-performance, the Lenovo ThinkCentre M Series Gen 6 AIO desktops offer efficient power with an immersive display. Designed for the most demanding industries, including those requiring 3D visualization such as healthcare, creativity, and education, the new generation of AIOs can deliver up to 260 TOPS of AI performance with Intel® Core™ ultra processors. Select models, such as the ThinkCentre M90a Gen 6, feature a 23.8” near edgeless FHD anti-glare display with 99% sRGB color accuracy, a smooth 120Hz refresh rate1 for crisp visuals, and certifications for EyeSafe® and IP55 water and dust resistance.2
Lenovo’s new ThinkCentre M Series Gen 6 desktops come with Lenovo’s proprietary AI solutions, including Lenovo AI Now on-device personal assistant to enhance workflow productivity and automation and Lenovo AI Turbo Engine that continuously allocates resources to optimize performance based on workload, and are backed by Lenovo ThinkShield, a comprehensive end-to-end security solution that combines hardware and software to protect your data. For additional security, they spot a dTPM 2.0 chip that encrypts passwords and data, a BIOS-based Smart USB protection and individual USB port disablement to help prevent unauthorized access via peripherals, and more.
Visual Performance and Versatile Connectivity
The ideal choice for modern professionals, Lenovo’s ThinkVision T Series Gen 40 monitors deliver performance that cater to individual needs. The family of WQHD and UHD IPS displays feature a wide 99% sRGB & BT.709 color gamut for accurate and vibrant images and a variable refresh rate3 (48-120Hz) that dynamically adjusts to match on-screen content for long term energy saving and smooth visuals. Designed to boost efficiency, each monitor sports an array of connectivity options, including USB-C® one cable solution on ThinkVision docking monitors, built-in modular VoIP remote conference technologies with AI-powered features4 and more. Select units offers fast device charge with up to 100W power delivery.5
Responsible Design and Centralized Management
Lenovo’s commitment to the increased use of more sustainable materials6 is reflected in the lineup of ThinkVision T Series Gen 40 monitors, using 95% post-consumer recycled plastic7 with plastic-free packaging. The lineup is also certified to meet the industry’s most rigorous environmental standards, including ENERGY STAR®, TCO, and EPEAT Gold8. For IT managers, Lenovo Display Fleet Manager (LDFM) enhances remote manageability with centralized asset management, firmware updates, and display setting configurations. With LDFM, firmware updates in around a minute and can be deployed in batches to minimize downtime for end-users.
About Lenovo
Lenovo is a US$57 billion revenue global technology powerhouse, ranked #248 in the Fortune Global 500, and serving millions of customers every day in 180 markets. Focused on a bold vision to deliver Smarter Technology for All, Lenovo has built on its success as the world’s largest PC company with a pocket-to cloud portfolio of AI-enabled, AI-ready, and AI-optimized devices (PCs, workstations, smartphones, tablets), infrastructure (server, storage, edge, high performance computing and software defined infrastructure), software, solutions, and services. Lenovo’s continued investment in world-changing innovation is building a more equitable, trustworthy, and smarter future for everyone, everywhere. Lenovo is listed on the Hong Kong stock exchange under Lenovo Group Limited (HKSE: 992) (ADR: LNVGY). To find out more visit https://lenovo.com and read about the latest news via our StoryHub.
1 Actual refresh rate may vary based on app/content limitations and requirements, device mode settings, and other factors.
2 IP55 water and dust resistance on the front face of selected models only. Water and dust resistance were tested to IP55 standards under controlled laboratory conditions. Protected against fresh water projected by a nozzle (6.3mm) against the enclosure from any direction. Exposure to conditions beyond this rating is not covered by warranty. Resistance will decrease as a result of normal wear. Do not expose to liquids other than fresh water. Do not attempt to charge a wet phone. Designed to provide protection against the ingress of solid foreign objects of a size larger than 1mm. Not waterproof or dust proof.
3 Variable Refresh Rate is supported as specified in HDMI 2.1 / Dynamic Refresh Rate is available for Microsoft Windows
4 Only available with ThinkVison T24D-4v, ThinkVision T27QD-4v and ThinkVision T24-4v.
5 Output rating of 100W (20V/5A) based on Lenovo’s proprietary VDM technology.
6 Full details of Lenovo’s commitment to sustainability found at https://www.lenovo.com/us/en/about/sustainability/
7 ITE-derived plastic in the front bezel, rear cover, arm cover, and base cover.
8 EPEAT-registered where applicable — see www.epeat.net for registration status by country.
LENOVO, THINKCENTRE, THINKVISION and THINKSHIELD are trademarks of Lenovo. Intel, Intel Core, Intel vPro and Thunderbolt are trademarks of Intel Corporation or its subsidiaries in the U.S. and/or other countries. USB Type-C® and USB-C® are registered trademarks of USB Implementers Forum. All other trademarks are the property of their respective owners. ©2025 Lenovo Group Limited. All rights reserved.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250514137029/en/
Contacts
Pedro Chen, pchen25@lenovo.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Regnology Signs an Agreement to Acquire Moody’s Regulatory Reporting & ALM Solutions18.12.2025 10:00:00 CET | Press Release
Regnology, a leading provider in regulatory, risk, tax, and finance reporting, as well as supervisory technology, today announced it has signed an exclusive agreement for the acquisition of Moody’s Regulatory Reporting & ALM Solutions business, inclusive of solutions for Basel III compliance, IFRS9 impairment accounting, large bank asset-liability management (ALM), Solvency II insurance reporting, and prudential and statistical regulatory reporting across more than 50 jurisdictions. By integrating Moody’s regulatory capital and liquidity capabilities with Regnology’s regulatory, risk, and finance offerings, the firm is creating a unified, scalable platform designed to meet the full spectrum of financial regulatory compliance and risk requirements. This combined strength positions Regnology as the partner of choice for financial institutions seeking future-ready solutions. At the core of this strategy is Regnology Risk Hub (RRiskHub), an integrated solution designed to deliver a single
Reply Recognized as a Microsoft Azure Expert Managed Services Provider for the Sixth Consecutive Year18.12.2025 10:00:00 CET | Press Release
Reply [EXM, STAR: REY] announced today it has been recognized once again as a Microsoft Azure Expert Managed Services Provider (MSP). The renewal reaffirms Reply’s proven expertise and consistent track record in delivering high-quality cloud solutions and services on the Microsoft Azure platform, powered by the deep technical expertise of its specialized companies – Cluster Reply, Solidsoft Reply and Valorem Reply. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218596617/en/ This recognition reflects the ongoing collaboration between Reply - through its companies Cluster Reply, Solidsoft Reply, and Valorem Reply - and Microsoft, supporting shared efforts to deliver value-driven services to enterprise customers. The Azure Expert MSP program is designed by Microsoft to identify and validate partners with proven capabilities in delivering end-to-end Azure services at scale. To qualify, partners must meet a strict set of requ
Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment18.12.2025 09:00:00 CET | Press Release
Takeda(TSE:4502/NYSE:TAK)today announced positive topline results for the two pivotal Phase 3randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO). The studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoints, static Physician Global Assessment (sPGA) 0/1 and Psoriasis Area and Severity Index (PASI) 75, at week 16, with a significantly greater PASI 75 response rate seen as early as week 4 and continuing to increase through week 24. The studies also met all 44 ranked secondary endpoints, including PASI 90, PASI 100 and sPGA 0 against placebo and apremilast, showing the potential of a convenient once-daily pill to deliver complete skin clearance for patients with PsO. “People living with psoriasis continue to seek safe, effective and fast-acting oral therap
DATROWAY ® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy18.12.2025 08:30:00 CET | Press Release
The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Products for Human Use. The application is based on data from the TROPION-Breast02 phase 3 trial presented in a late-breaking proffered paper session at the 2025 European Society for Medical Oncology (#ESMO25) Congress. In the trial, DATROWAY demonstrated statistically significant and clinical
Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector18.12.2025 03:41:00 CET | Press Release
Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a biosimilar to Stelara® (ustekinumab), for the treatment of plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD). The positive CHMP opinion is for SteQeyma autoinjector in 45mg/0.5mL and 90mg/1mL, expanding the currently approved SteQeyma™ presentation, which includes 45mg/0.5mL, 90mg/1mL in a pre-filled syringe and 45mg/0.5mL in a vial for subcutaneous injection, as well as 130mg/26mL concentrate for solution for intravenous infusion. “The new SteQeyma™ autoinjector brings together convenience and practical usability to meet the everyday challenges faced by patients living with chronic inflammatory diseases. The full range of our SteQeyma™ dosage forms and strengths, with the autoinjector now added, provides patients and healthcare professionals with more individualized treatm
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom